Cancer Research and You: Understanding Clinical Trials
Wondering what clinical trials are all about and if they are right for you? Join us for the first part of GRYT Health’s Research Program Series, Cancer Research & You. We will be discussing clinical trials, their importance in advancing cancer care, how you can find clinical trials and common misconceptions about them. This will be an interactive and informative program with the opportunity to ask cancer research professionals from our partner, Ancora.ai and our own Dr. Dan, some of your biggest questions about clinical trials.
- Emily Jordan, PhD, Ancora.ai
- Dan Platt, MD, Chief Medical Officer, GRYT Health
Emily Jordan, PhD, Ancora.ai
Emily Jordan PhD, is the COO and cofounder of Ancora.ai. Ancora.ai's mission is to empower every patient to understand and have access to clinical research, as well as to support them throughout the clinical trial journey. Emily has a PhD in neuroscience from the University of Cambridge, where she was a Gates Cambridge Scholar, and an undergraduate degree from Columbia. She has spent her career working at the intersection of science and tech, and has a passion for improving health equity. At Ancora.ai, Emily leads patient outreach and education, content creation and operations.
Dan Platt, MD, Chief Medical Officer, GRYT Health
Dan Platt, MD, is the chief medical officer at GRYT Health. He has spent the majority of his life engaged in making the healthcare system more responsive to the needs of patients. Dan holds a Doctor of Medicine (M.D.) degree with distinction in research from the University of Rochester School of Medicine and Dentistry. He recently moved back to Rochester after having spent the last 10 years in Boston as a resident in neurology and consultant to biotech, pharma, and industry. Dan has extensive experience in the immuno-oncology space, having also served as the Executive Director, Medical Strategy and Development, for Advaxis Immunotherapies. He is passionate about improving the prevention and treatment of cancer, educating and advocating for patients, and reshaping healthcare to be effective, efficient, and equitable.